Search research articles
Contact Us
Filters
Showing results (201-210 of 442) with videos related to
Page
of 45
Sort By:
The American Journal of Pathology
|
March 2, 2006
Inhibition of SRC expression and activity inhibits tumor progression and metastasis of human pancreatic adenocarcinoma cells in an orthotopic nude mouse model
Jose G Trevino, Justin M Summy, Donald P Lesslie, et al.
Journal of Immunotherapy and Precision Oncology
|
June 6, 2022
Role of Abdominal and Pelvic CT Scans in Diagnosis of Patients with Immunotherapy-Induced Colitis
Juan Ibarra Rovira, Selvi Thirumurthi, Melissa Taggart, et al.
Journal of Gastrointestinal Cancer
|
April 29, 2023
Utility of Established Prognostic Scoring Systems for Patients with Advanced Pancreatic Adenocarcinoma Enrolled in Immunotherapy-Based Early-Phase Clinical Trials
Rishi Surana, Graciela Nogueras Gonzalez, Jane Rogers, et al.
Journal for Immunotherapy of Cancer
|
January 17, 2025
Phase I study of BMS-986299, an NLRP3 agonist, as monotherapy and in combination with nivolumab and ipilimumab in patients with advanced solid tumors
Blessie E Nelson, Shaun O'Brien, Rahul A Sheth, et al.
Journal of Affective Disorders
|
August 28, 2022
General Anxiety Disorder-7 Questionnaire as a marker of low socioeconomic status and inequity
Julio C Nunes, Megan K Carroll, Kenneth W Mahaffey, et al.
Science Advances
|
May 20, 2020
Mathematical prediction of clinical outcomes in advanced cancer patients treated with checkpoint inhibitor immunotherapy
Joseph D Butner, Dalia Elganainy, Charles X Wang, et al.
Current Pharmaceutical Biotechnology
|
May 22, 2014
Impact of microRNAs in resistance to chemotherapy and novel targeted agents in non-small cell lung cancer
Christian Rolfo, Daniele Fanale, David S Hong, et al.
The Oncologist
|
March 27, 2014
Incidence of mucositis in patients treated with temsirolimus-based regimens and correlation to treatment response
Xiaochun Liu, Patricia Lorusso, Monica Mita, et al.
Oncoscience
|
January 17, 2015
Dual EGFR inhibition in combination with anti-VEGF treatment in colorectal cancer
Gerald S Falchook, Aung Naing, Jennifer J Wheler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 4, 2026
Convergence of KRAS Mutations and MTAP Loss in Pancreatic Cancer: Genomic Landscape and Clinical Implications
Camila Braganca Xavier, Pooja A Shah, Daria Yakimova, et al.
Page
of 45
Search research articles
Search
Showing results (201-210 of 442) with videos related to
Sort By:
Page
of 45
The American Journal of Pathology
|
March 2, 2006
Inhibition of SRC expression and activity inhibits tumor progression and metastasis of human pancreatic adenocarcinoma cells in an orthotopic nude mouse model
Jose G Trevino, Justin M Summy, Donald P Lesslie, et al.
Journal of Immunotherapy and Precision Oncology
|
June 6, 2022
Role of Abdominal and Pelvic CT Scans in Diagnosis of Patients with Immunotherapy-Induced Colitis
Juan Ibarra Rovira, Selvi Thirumurthi, Melissa Taggart, et al.
Journal of Gastrointestinal Cancer
|
April 29, 2023
Utility of Established Prognostic Scoring Systems for Patients with Advanced Pancreatic Adenocarcinoma Enrolled in Immunotherapy-Based Early-Phase Clinical Trials
Rishi Surana, Graciela Nogueras Gonzalez, Jane Rogers, et al.
Journal for Immunotherapy of Cancer
|
January 17, 2025
Phase I study of BMS-986299, an NLRP3 agonist, as monotherapy and in combination with nivolumab and ipilimumab in patients with advanced solid tumors
Blessie E Nelson, Shaun O'Brien, Rahul A Sheth, et al.
Journal of Affective Disorders
|
August 28, 2022
General Anxiety Disorder-7 Questionnaire as a marker of low socioeconomic status and inequity
Julio C Nunes, Megan K Carroll, Kenneth W Mahaffey, et al.
Science Advances
|
May 20, 2020
Mathematical prediction of clinical outcomes in advanced cancer patients treated with checkpoint inhibitor immunotherapy
Joseph D Butner, Dalia Elganainy, Charles X Wang, et al.
Current Pharmaceutical Biotechnology
|
May 22, 2014
Impact of microRNAs in resistance to chemotherapy and novel targeted agents in non-small cell lung cancer
Christian Rolfo, Daniele Fanale, David S Hong, et al.
The Oncologist
|
March 27, 2014
Incidence of mucositis in patients treated with temsirolimus-based regimens and correlation to treatment response
Xiaochun Liu, Patricia Lorusso, Monica Mita, et al.
Oncoscience
|
January 17, 2015
Dual EGFR inhibition in combination with anti-VEGF treatment in colorectal cancer
Gerald S Falchook, Aung Naing, Jennifer J Wheler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 4, 2026
Convergence of KRAS Mutations and MTAP Loss in Pancreatic Cancer: Genomic Landscape and Clinical Implications
Camila Braganca Xavier, Pooja A Shah, Daria Yakimova, et al.
Page
of 45